Do simultaneous left ventricular volume and strain changes during chemotherapy associate with 2-year postchemotherapy declines in LVEF in patients receiving potentially cardiotoxic chemotherapy?
Changes in left ventricular volume and strain during cardiotoxic chemotherapy can help identify patients at risk for long-term declines in LVEF.
=0.036). Conclusion During receipt of potentially cardiotoxic chemotherapy, increases in LVESV, the absence of its deterioration during decreases of left ventricular end-diastolic volume, or the deterioration of global circumferential strain without a marked decrease in LVESV help identify those who will develop more permanent 2-year declines in LVEF.
Suerken et al. (Tue,) studied this question.